 | | | | Related Healthscout Videos | |
|
TUESDAY, Sept. 30 (HealthDay News) -- Children vaccinated against hepatitis B probably are not at an increased risk of developing multiple sclerosis (MS) unless they were inoculated with a particular brand of the vaccine, according to a new study.
The French study found that children with MS were almost twice as likely to have received the vaccine called Engerix B three or more years before the disease's onset. Further studies will need to be done to determine whether the vaccine is a direct cause of the development of MS.
Text Continues Below
The study, which involved 349 children with MS and 2,941 children without the disease, is to be published in the Oct. 8 online issue of Neurology.
More information
The U.S. Centers for Disease Control and Prevention has more about vaccinations.
-- Kevin McKeever
|
.gif)
